↓ Skip to main content

Dove Medical Press

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review

Overview of attention for article published in Drug Design, Development and Therapy, June 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
3 X users
patent
3 patents
facebook
1 Facebook page

Citations

dimensions_citation
277 Dimensions

Readers on

mendeley
220 Mendeley
Title
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
Published in
Drug Design, Development and Therapy, June 2016
DOI 10.2147/dddt.s97653
Pubmed ID
Authors

Shiqi Yang, Jingke Zhao, Xiaodong Sun

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 <1%
Unknown 219 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 14%
Researcher 29 13%
Student > Master 22 10%
Student > Bachelor 14 6%
Student > Doctoral Student 13 6%
Other 33 15%
Unknown 79 36%
Readers by discipline Count As %
Medicine and Dentistry 52 24%
Biochemistry, Genetics and Molecular Biology 26 12%
Pharmacology, Toxicology and Pharmaceutical Science 15 7%
Agricultural and Biological Sciences 13 6%
Neuroscience 7 3%
Other 24 11%
Unknown 83 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2023.
All research outputs
#3,082,856
of 25,837,817 outputs
Outputs from Drug Design, Development and Therapy
#162
of 2,285 outputs
Outputs of similar age
#51,389
of 355,148 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 65 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,285 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,148 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.